In 2022-2023, the Center for Teaching Innovation awarded five Innovative Teaching & Learning Awards to Cornell faculty. With a goal of facilitating vibrant, challenging, and reflective learning experiences at Cornell, these awards sponsor projects across the colleges that explore new tools and emerging technologies, approaches, and teaching strategies. CTI is now accepting pre-applications for the 2023-2024 Innovative Teaching and Learning Awards – the deadline is April 17.
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study by scientists at Weill Cornell Medicine.
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.
Adrienne Bitar specializes in the history and culture of American food and health and, says Americans are increasingly looking beyond traditional diets towards “whole health philosophies” and “lifestyle plans” that promote physical and societal health.
The Division of Nutritional Sciences and partner RTI International won a five-year, $23 million award to coordinate research for the NIH’s Nutrition for Precision Health study.
Post-operative atrial fibrillation may be a marker for early-stage heart failure and may potentially contribute to its development, according to a new study.
From monitoring blood pressure to potholes: Professor Max Zhang's Internet of Things (IoT) course teaches students how to leverage IoT sensor technology to solve real-world problems and help the community.
A new Cornell-led project will accelerate the application of a proven biotechnology to enhance food and nutritional security in Bangladesh and the Philippines while protecting the health of farmers and the environment.
During his term as president of the American Association of Immunologists, Dr. Gary Koretzky '78, vice provost for academic integration at Cornell, aims to improve science advocacy, public outreach and more.
The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and NYU Grossman School of Medicine.
